There’s one area that’s increasingly vulnerable to cyberattacks and alluring to bad actors: trials data. It’s not only a goldmine of personal health information (PHI), but also rich with competitive and proprietary information that’s ripe for industrial espionage. That vulnerability might also be leading to lower enrollment as potential trial participants become more wary of sharing their data.